Superficial vein thrombosis
Superficial vein thrombosis (SVT) is a medical condition characterized by the formation of a blood clot in a superficial vein, which is located near the surface of the body. This condition is often associated with inflammation and can lead to complications such as deep vein thrombosis and pulmonary embolism if not treated promptly.
Causes[edit | edit source]
The exact cause of SVT is not known, but several factors can increase the risk of developing this condition. These include prolonged immobility, certain medical conditions such as cancer or blood disorders, and certain medications. Smoking and obesity are also risk factors for SVT.
Symptoms[edit | edit source]
The most common symptom of SVT is a painful, red, and swollen area along the course of a superficial vein. Other symptoms may include skin discoloration, warmth over the affected area, and a hard vein that can be felt through the skin.
Diagnosis[edit | edit source]
SVT is typically diagnosed through a physical examination and medical history. In some cases, an ultrasound may be used to confirm the diagnosis and rule out other conditions such as deep vein thrombosis.
Treatment[edit | edit source]
Treatment for SVT typically involves measures to reduce inflammation and prevent the formation of new clots. This may include the use of nonsteroidal anti-inflammatory drugs (NSAIDs), compression stockings, and elevation of the affected limb. In some cases, anticoagulant medications may be prescribed to prevent the clot from extending into the deep veins.
Prevention[edit | edit source]
Prevention of SVT involves addressing the underlying risk factors. This may include maintaining a healthy weight, quitting smoking, and managing any underlying medical conditions. Regular exercise and movement can also help to prevent SVT, particularly for individuals who are immobile for prolonged periods.
See also[edit | edit source]
Superficial vein thrombosis Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD